Renasant Bank Edwards Lifesciences Corp Transaction History

Renasant Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$69.28 - $93.38 $25,356 - $34,177	-366 Reduced 7.59%	4,459 $308,000
Q2 2023 Aug 01, 2023	SELL	$81.41 - $94.33 $56,417 - $65,370	-693 Reduced 12.56%	4,825 $455,000
Q1 2023 May 05, 2023	SELL	$74.26 - $84.51 $76,636 - $87,214	-1,032 Reduced 15.76%	5,518 $456,000
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $78,340 - $100,293	1,147 Added 21.23%	6,550 $488,000
Q3 2022 Nov 03, 2022	BUY	$82.37 - $107.29 $60,789 - $79,180	738 Added 15.82%	5,403 $446,000
Q2 2022 Aug 03, 2022	SELL	$86.5 - $128.27 $2,422 - $3,591	-28 Reduced 0.6%	4,665 $444,000
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $3,568 - $4,491	35 Added 0.75%	4,693 $553,000
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $1,170 - $1,437	-11 Reduced 0.24%	4,658 $604,000
Q2 2021 Jul 19, 2021	SELL	$83.84 - $104.76 $14,420 - $18,018	-172 Reduced 3.55%	4,669 $484,000
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $9,126 - $10,517	-116 Reduced 2.34%	4,841 $405,000
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $355,367 - $452,227	4,957 New	4,957 $452,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

Stay updated on Renasant Bank with notifications on news.